Results 171 to 180 of about 863,965 (187)
Some of the next articles are maybe not open access.
Targeting CD73 in the tumor microenvironment with MEDI9447
OncoImmunology, 2016Melissa Damschroder +2 more
exaly
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
Investigational New Drugs, 2012Robert L Coleman +2 more
exaly

